BBS Pharmaceuticals is an Australian company licensed to cultivate, produce and manufacture medicinal cannabis products for the Australian and Global medicinal cannabis market.
Founded in South Australia in June of 2017; BBS Pharmaceuticals, is a South Australian company with dedicated directors and a growing team of management, staff and global partners.
Our aim is to be the leading medicinal Cannabis cultivator and manufacturer in Australia, to have strong market connections at an international scale, as well as influence the Australian and South east Asian market as a leader in this industry.
The 5 year target for BBS is to be “The leading” medicinal Cannabis cultivator and manufacturer in Australia, to have strong market connections at a global level, as well as influence the Australian and South east Asian market as leader in this industry.
The BBS board with the guidance and leadership of their CEO, have developed a sound business growth strategy under an operational framework. Currently the team is working on the final phase of the planning and development of the facility with Local, State and Federal Government oversee. Under the guidance of their newly appointed CEO and their strategic advisors, the board has developed a business ready, operational framework and a robust business plan which includes capital costs, operation expenditure as well as operational revenue forecasting.